Taysha buys clinic-ready gene therapy from Abeona, bringing Steven Gray's portfolio back in one place
Less than four months after Taysha launched with a suite of AAV gene therapies developed at UT Southwestern — and two weeks after the ex-AveXis team …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
